![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/32 | (2006.01) |
A61K 47/32 | (2013.01) | ||
A61K 9/14 | (2006.01) | ||
A61K 9/10 | (2013.01) | ||
A61K 31/557 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61K 9/10 | (2006.01) | ||
A61K 31/785 | (2013.01) | ||
A61P 9/12 | (2006.01) | ||
A61K 47/585 | (2017.08) | ||
A61K 31/192 | (2013.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61P 9/10 | (2018.01) | ||
A61P 9/12 | (2018.01) |
(11) | Number of the document | 3164155 |
(13) | Kind of document | T |
(96) | European patent application number | 15731463.4 |
Date of filing the European patent application | 2015-06-12 | |
(97) | Date of publication of the European application | 2017-05-10 |
(45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/035595 |
Date | 2015-06-12 |
(87) | Number | WO 2015/192030 |
Date | 2015-12-17 |
(30) | Number | Date | Country code |
201462011689 P | 2014-06-13 | US |
(72) |
PHARES, Ken , US
CHANG, Courtney , US
|
(73) |
United Therapeutics Corporation ,
1040 Spring Street, Silver Spring, MD 20910,
US
|
(54) | TREPROSTINIL FORMULATIONS |
TREPROSTINIL FORMULATIONS |